Introduction
Moyamoya disease (MMD), translated in Japanese as hazy or puffy, is a chronic progressive occlusive arteriopathy of the anterior cerebral circulation. The vascular pathology of MMD causes large intracranial artery occlusion and collateral circulation leading to acute infarcts, which have a higher tendency to develop recurrent strokes causing a significant cognitive impairment and neurologic decline. 1, 2 Overall incidence of Moyamoya is 0.086 cases per 100,000 people. MMD has the highest prevalence among Japanese children (6.03 per 100,000). An increase in the prevalence of Moyamoya has been demonstrated among non-Asian populations. The reported occurrence in the Caucasian population in the US is the highest compared to other populations, but Caucasians represent 72.4% of the US population. In general, Moyamoya disease is observed among the various races based on their proportions of the total US population. 3 The occurrence of the disease shows a bimodal age distribution at 5-9 years and 35-50 years with female predominance. 4 The exact etiology of MMD is unknown, however the increased familial incidence suggests a genetic cause. Accumulating evidence suggests that the RNF213 gene on chromosome 17q25.3 is an important susceptibility factor for MMD in East Asian populations. 5, 6 In a report from Japan, the c.14576 G>A variant of RNF213 was found in 95% of 41 patients with familial MMD, 79% of 163 patients with sporadic MMD, and 2% of 283 normal control subjects. 6 Other studies have linked familial Moyamoya disease to chromosomes 3p24.2-p26, 6q25, 8q23, and 12p12. 7, 8 Familial cases of MMD in the US are approximately 2%, but in Japan a family history of Moyamoya disease is present in 12.1% of patients. Environmental factors can be considered as contributing factors to this observation. 3, 9 Especially in North American patients the clinical presentation can be atypical with a later onset and may cause a delay of the diagnosis. These patients are less likely to have hemorrhagic stroke. 10, 11 Kuroda et al. published in 2005 an article about the clinical features of MMD in adults indicating that the disease has a high rate of progression, even in asymptomatic patients, and medical alone cannot stop the disease progression. 12 Over a period of 5 years about 70% of the MMD-patients experience a symptomatic progression; without a treatment the disease outcome is poor. 13 In contrast surgical intervention may be more beneficial. A meta-analysis of 2005 on pediatric patients involving 1156 subjects showed that symptomatic disease progression occurred only in 2.6% of the patients after surgery. 14 We describe a case series of advanced Moyamoya disease in a Hispanic male and protracted Moyamoya syndrome in a Hispanic female with an acute, fulminant and protracted progression, respectively.
Case Report #1
A 42-year-old Hispanic male without significant past medical history presented with a 4-week history of slow mentation, difficulty concentrating, and change in personality. He complained of bilateral lower extremity weakness, as well as a presyncopal episode and sudden onset of numbness involving his right body side 3 days before admission. Other symptoms included intermittent nausea and vomiting. Physical examination included slow mentation, impaired concentration, facial weakness of the right lower half, dysarthria, and mild weakness in the lower extremities without sensory level or sphincter dysfunction. Full strength in his upper extremities, diminished reflexes throughout, and intact sensation were noted. No cerebellar dysfunction, nystagmus, or Babinski signs were present. Laboratory tests for systemic autoimmune, inflammatory, and infectious diseases, and neoplasm were all negative.
Initial unenhanced head computed tomography (CT) showed hypodense lesions in the body and genu of the corpus callosum and right basal ganglia. A subsequent brain magnet-resonance-imaging revealed multiple supratentorial lesions involving the rostrum of the corpus callosum, genu of the right internal capsule and basal ganglia and subcortical cingulate white matter, with variable degrees of enhancement associated with mass effect (Figure 1 ). Initial differential diagnoses included an acute demyelinating process versus primary CNS lymphoma, glioma, or acute/subacute ischemic infarct.
Cerebrospinal fluid analysis (CSF) showed mild increase of total protein and elevated CSF levels of myelin basic protein, without oligoclonal bands. High doses of intravenous methylprednisolone (1 gm/day) were administered; 72 hours after admission, the patient developed altered level of consciousness, aphasia, left gaze deviation, and right hemiplegia.
Cerebral angiography (Figure 2 ) demonstrated bilateral intracranial arteriopathy with occlusion of the supraclinoid segment of the left intracranial internal carotid artery distal to the takeoff of the left anterior choroidal artery, occlusion of the right anterior cerebral artery, and severe dis ease in the proximal right middle cerebral artery. The distal branches of the right middle and anterior cerebral arteries were mainly fed by collateral anastomoses from the anterior and posterior choroidal arteries, producing arterial blush (puff of smoke) consistent with an angiographic Moyamoya pattern.
Within few days the patient developed a massive infarction involving almost the entire left hemisphere and the bilateral anterior cerebral arterial territories, associated cerebral edema, midline shift complicated by brain herniation, and eventually death 11 days after admission.
Case Report #2
A 29-year old Hispanic female with a significant past medical history for repaired patent foramen ovale, pulmonary valve stenosis and right ventricular outflow obstruction, which were both surgically treated 2 years ago presented with 3-days history of severe bifrontal headache and altered mental status. Physical examination and laboratory workup were unremarkable. Head-CT demonstrated subarachnoid hemorrhage seen throughout basilar cisterns including suprasellar, interpeduncular, perimesencephalic, and prepontine cisterns. Head-CT-angiography (CTA) showed bilateral intracranial internal carotid artery (ICA) occlusion with concentric luminal narrowing of the cervical ICAs, diffuse intracranial proliferative arteriopathy in the bilateral territories of the anterior and middle cerebral arteries and ruptured saccular aneurysm arising from the right posterior cerebral artery. Cerebral angiogram confirmed these findings and a coiling embolization of a ruptured 3.5 mm high flow aneurysm arising from the distal aspect of the basilar artery was performed. The angiogram also demonstrated bilateral severe stenosis of the internal carotid arteries with multiple transdural collaterals consistent with moyamoya angiographic pattern ( Figure  3 ). The neurosurgery service was consulted, however the patient refused further surgical evaluation and was discharged on the 7 th day of hospitalization. Unfortunately the patient did not follow up with neuroradiology and neurosurgery and presented 15 months later with acute onset of altered level of consciousness. She was intubated in the emergency department, placed on mechanical ventilation and admitted with a Glasgow Coma Scale (GCS) of 6 to the medical intensive care unit. The repeat-head-CT showed extensive hemorrhage confined to the choroid plexus bilaterally involving the third and forth ventricles resulting in a left-to-right 4 mm midline shift with moderate hydrocephalus. On the following day her GCS declined to 3 and her cardiac rhythm changed to bradycardia and later asystole. Cardiopulmonary resuscitation was unsuccessful and the patient died on the following day of hospitalization.
Discussion
Moyamoya disease is an idiopathic progressive intracranial occlusive arteriopathy, which can be complicated with ischemic and hemorrhagic cerebrovascular events. The angiographic feature of collateralization is pathognomonic for Moyamoya pattern. The Moyamoya syndrome can be associated with severe intracranial atherosclerotic disease, sickle cell disease, neurofibromatosis type I, cranial radiation therapy, and trisomy 21. 15 Typically moyamoya disease and moyamoya syndrome present during childhood, however the incidence of both forms in North America occurs in the mid-40s. 3 Diagnostic criteria for idiopathic moyamoya include the following major requirements: stenosis or occlusion at the terminal portion of the internal carotid artery and at the proximal portion of the anterior and middle cerebral arteries on MRA or conventional cerebral angiography; abnormal vascular networks in the basal ganglia on MRA; angiographic findings are present bilaterally. 16 Magnet-resonance imaging is the preferred radiological modality. Contrast-enhanced T1-weighted images and FLAIR (fluid-attenuated inversion recovery) images can show a linear pattern of increased signal in the leptomeninges and perivascular spaces, known as the ivy sign. Transcranial Doppler ultrasonography (TCD) can be used to evaluate large artery stenosis and intracranial hemodynamics by measuring blood flow velocity of the large intracranial vessels at the circle of Willis. SPECT can also be used to demonstrate the decrease blood and oxygen supply to areas of the brain. 17, 18 Overall, the acute treatment goals are to reduce intracranial pressure, improve cerebral blood flow and control any seizures. Ventricular drainage and/or hematoma removal may be required. Thrombolytic therapy in the event of ischemic stroke is not recommended, since adults usually present with a hemorrhagic stroke as the collaterals have a tendency to rupture. 19 Surgical revascularization is advised in both children and adults presenting with progressive symptoms and/or cognitive decline. There are multiple surgical options, but the treatment of choice is thought to be a direct superficial temporal artery to middle cerebral artery bypass (external carotid-internal carotid bypass surgery). 20 Other surgical modalities including EDAS (encephaloduroarteriosynangiosis), EMS (encephalomyosynangiosis), and the multiple burr holes procedure are available, however the outcome remains controversial.
Conclusions
We describe an uncommon variety of moyamoya presentation in the setting of moyamoya disease with a fulminant progression (case 1) and moyamoya syndrome with delayed presentation but also with fatal outcome (case 2).
Despite the limited prognosis and the evidences known about the disease progression a fulminant course with multiple bilateral large lobar infarcts precipitating herniation and death within days is uncommon (case 1). In contrast subarachnoid hemorrhage as a result of saccular aneurysmatic formation in the setting of moyamoya syndrome is more common. However neurointerventional procedures may not hold the disease progression but can prolong survival (case 2). The outcome in both settings remains unfortunately the same.
While definitive treatment in the acute fulminant phase may be futile and not indicated, ascertaining the correct diagnosis may help provide a more accurate prognosis. 
